An Active Surveillance, Post-Authorization Safety Study to Characterize the Safety of Etrasimod in Patients with Ulcerative Colitis Using Real-World Data in the European Union (C5041046)

09/01/2026
30/06/2026
EU PAS number:
EUPAS1000000895
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

C5041046_ETRASIMOD PROTOCOL VERSION 3_07JULY2025_Clean.pdf

English (1.33 MB - PDF) View document
Updated protocol

C5041046_ETRASIMOD PROTOCOL VERSION 4.0_21MAY2026.pdf

First published: 29/06/2026
English (1003.85 KB - PDF) View document
Study results
Study report
Other information